Sign in
4

Changes in Ownership

PLIANT THERAPEUTICS, INC. Filed Acc 0001746473-26-000012

Chief Financial Officer sold 24,002 shares at $1.28 ($30,723)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cummings Keith Lamont Chief Financial Officer 2026-01-20 Sale 10b5-1 −24,002 $1.28 $30,723 297,214 D: show line 1 in the form
Open-market sales · 24,002 sh · avg $1.28 · $30,723
Loading xslF345X05/wk-form4_1769136395.xml…